Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
106.9 USD | -0.65% | +0.93% | -2.89% |
Apr. 23 | Daiwa Securities Trims Abbott Laboratories Price Target to $125 From $126 | MT |
Apr. 22 | Barclays Adjusts Abbott Laboratories' Price Target to $140 From $141, Maintains Overweight Rating | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-2.89% | 185B | |
-2.43% | 107B | |
-4.10% | 67.55B | |
+11.10% | 54.6B | |
+15.86% | 47.42B | |
+3.86% | 42.24B | |
+9.55% | 28.24B | |
+1.85% | 26.42B | |
+12.40% | 25.66B | |
-0.44% | 24.9B |
- Stock Market
- Equities
- ABT Stock
- News Abbott Laboratories
- Abbott Laboratories : Third-Quarter Results Beat Views With Revenue Getting COVID-19 Test Boost as Full-Year EPS Outlook Lifted